Therapy News and Research

RSS

Northwestern scientists receive awards totaling nearly $18 million for Parkinson's disease research

Northwestern University scientists have received two awards totaling nearly $18 million for Parkinson's disease research from The ASAP Collaborative Research Network, a program of the Aligning Science Across Parkinson's (ASAP) initiative being implemented through The Michael J. Fox Foundation.

27 Oct 2021

Bone loss after menopause significantly lower than previously assumed

Bone mineral density at the femoral neck bone in postmenopausal women decreased by an average of 10% during a 25-year follow-up, according to a new study from the University of Eastern Finland.

27 Oct 2021

COVID-19 vaccine-elicited immune responses in myeloma patients

Researchers collaborated to address these evidence gaps by initiating a web-based prospective study of adults diagnosed with multiple myeloma to determine the immune response to the first and second dose of the COVID-19 vaccine.

27 Oct 2021

Cholesterol-lowering drugs not helpful in reducing COVID-related mortality or severity

In the worldwide effort to battle SARS-CoV-2, the virus that causes COVID-19, researchers have often turned to medications used as therapies for other conditions in the hopes of finding ones that either kill the coronavirus or lessen the impacts from its infection.

26 Oct 2021

HCV treatment decreases protein activity levels involved in liver cirrhosis, research shows

Researchers at the Medical University of South Carolina report in the Journal of Viral Hepatitis that the activity levels of the proteins involved in liver scarring, or cirrhosis, begin to decrease immediately after treatment for the hepatitis C virus (HCV), suggesting the possibility of early healing.

26 Oct 2021

Researchers receive $8.9 million grant to study the gut-brain connection in Parkinson’s disease

Dr. Michael Kaplitt, a professor of neurological surgery at Weill Cornell Medicine and a longtime leader in developing cutting-edge surgical therapies for movement disorders, leads a team that has been awarded a three-year, $8.9 million grant from the Aligning Science Across Parkinson's (ASAP) initiative.

26 Oct 2021

Hyperimmune antibody produced in horses may be an efficient approach to combat covid-19

A study conducted by a consortium of Brazilian researchers has demonstrated that a hyperimmune serum consisting of purified antibody fragments produced in horses may be an efficient approach to combat covid-19.

26 Oct 2021

Clinical trial shows no benefit of tamoxifen in treating deadly fungal meningitis

Hopes that tamoxifen could improve survival for a deadly form of fungal meningitis have been dashed by clinical trial results published in eLife.

26 Oct 2021

Consecutive irradiation with two lasers helps adult stem cells to transform faster

Stem cell therapy needs a lot of human cells, of a specific type. Shining a near-infrared laser on adult stem cells derived from human body fat, makes the stem cells replicate 54% faster.

26 Oct 2021

Effectiveness of mRNA BNT162b2 COVID-19 vaccine in immunocompromised individuals

Israeli researchers evaluate the antibody response in ICPs to assess antibody-mediated immunity following vaccination with the Pfizer-BioNTech vaccine.

26 Oct 2021

New treatment for HPV-associated oropharynx cancer leads to excellent disease control, less side effects

Mayo Clinic researchers have found that a new, shorter treatment for patients with HPV-associated oropharynx cancer leads to excellent disease control and fewer side effects, compared to standard treatment.

26 Oct 2021

Safer, more effective therapies could help fight the obesity epidemic

Novel obesity treatments such as modulation of the gut microbiome and gene therapy are underutilized and could help fight the obesity epidemic, according to a new manuscript published in the Endocrine Society's journal, Endocrine Reviews.

26 Oct 2021

Analysis: A procedure that cost $1,775 in New York was $350 in Maryland. Here’s why.

For the past 18 months, while I was undergoing intensive physical therapy and many neurological tests after a complicated head injury, my friends would point to a silver lining: "Now you'll be able to write about your own bills." After all, I'd spent the past decade as a journalist covering the often-bankrupting cost of U.S. medical care.

26 Oct 2021

MIP Diagnostics to support the development of challenging affinity reagents with new Molecular Imprinting Epitope Discovery

MIP Diagnostics has today announced the launch of its novel Molecular Imprinting Epitope Discovery Service.

26 Oct 2021

Study identifies how cancer cells transform macrophages into supporters of their growth

A Ludwig Cancer Research study has identified a means by which cancer cells engineer the conversion of immune cells known as macrophages from destroyers of tumors to supporters of their growth and survival.

26 Oct 2021

Researchers reveal mechanism which allows antibiotics like penicillin to kill MRSA

The mechanism which allows β-lactam antibiotics, including penicillin, to kill MRSA has been revealed for the first time.

25 Oct 2021

Intervention erases Black-white survival gaps in early-stage lung and breast cancer patients

A new study shows that system-level changes to the way cancer care is delivered can also eliminate Black-white disparities in survival from early-stage lung and breast cancer.

25 Oct 2021

New data reveals safety, efficacy of nusinersen drug delivery method for SMA patients with advanced disease

A recently published paper details the safety and efficacy of nusinersen administration via a subcutaneous intrathecal catheter system (SIC) for SMA patients with advanced disease.

25 Oct 2021

Researchers develop ferritin-based nanomedicine for targeted delivery of leukemia therapy

Researchers from the Institute of Process Engineering\ of the Chinese Academy of Sciences, Peking University and Zhujiang Hospital of Southern Medical University have developed a ferritin (Fn)-based nanomedicine for targeted delivery of arsenic (As) and efficient therapy against diverse leukemia types.

25 Oct 2021

Fewer, higher doses of post-prostatectomy radiation therapy does not increase long-term side effects

Using fewer - but higher - doses of radiation to treat men with prostate cancer who had their prostates removed does not increase long-term side effects or lower their quality of life compared to conventional radiation treatment, a new, multi-institutional clinical trial shows.

25 Oct 2021

Therapy News and Research

Northwestern scientists receive awards totaling nearly $18 million for Parkinson's disease research

Bone loss after menopause significantly lower than previously assumed

COVID-19 vaccine-elicited immune responses in myeloma patients

Cholesterol-lowering drugs not helpful in reducing COVID-related mortality or severity

HCV treatment decreases protein activity levels involved in liver cirrhosis, research shows

Researchers receive $8.9 million grant to study the gut-brain connection in Parkinson’s disease

Hyperimmune antibody produced in horses may be an efficient approach to combat covid-19

Clinical trial shows no benefit of tamoxifen in treating deadly fungal meningitis

Consecutive irradiation with two lasers helps adult stem cells to transform faster

Effectiveness of mRNA BNT162b2 COVID-19 vaccine in immunocompromised individuals

New treatment for HPV-associated oropharynx cancer leads to excellent disease control, less side effects

Safer, more effective therapies could help fight the obesity epidemic

Analysis: A procedure that cost $1,775 in New York was $350 in Maryland. Here’s why.

MIP Diagnostics to support the development of challenging affinity reagents with new Molecular Imprinting Epitope Discovery

Study identifies how cancer cells transform macrophages into supporters of their growth

Researchers reveal mechanism which allows antibiotics like penicillin to kill MRSA

Intervention erases Black-white survival gaps in early-stage lung and breast cancer patients

New data reveals safety, efficacy of nusinersen drug delivery method for SMA patients with advanced disease

Researchers develop ferritin-based nanomedicine for targeted delivery of leukemia therapy

Fewer, higher doses of post-prostatectomy radiation therapy does not increase long-term side effects

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News